Nailfold Capillaroscopy in the Evaluation of Autoimmune Diseases

Authors

  • Juliana Silva Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal
  • Petra Monteiro Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal
  • Ricardo Fernandes Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal
  • Joana Malheiro Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal
  • Carina Silva Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal
  • Paula Ferreira Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal
  • Andreia Seixas Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal
  • Victor Paixão Dias Serviço de Medicina Interna, Centro Hospitalar Vila Nova de Gaia/ Espinho, Vila Nova de Gaia, Portugal

DOI:

https://doi.org/10.24950/rspmi/O37/17/2017

Keywords:

Autoimmune Diseases, Capillaries, Microscopic Angioscopy, Nails/blood supply, Raynaud Disease, Scleroderma, Systemic

Abstract

Introduction: Nailfold capillaroscopy is a simple, safe and
noninvasive method, essential in the evaluation of the microcirculation
in vivo, and crucial to distinguish between
primary or secondary Raynaud’s phenomenon. Raynaud’s
phenomenon assumes its major importance in the spectrum
of systemic sclerosis diseases showing the early involvement
and the vascular changes in the microcirculation
before the onset of other clinical symptoms or organ
involvement, and creating an opportunity to prevent vascular
complications.
Methods: We analyzed, retrospectively, clinical data and
results of nailfold capillaroscopy from 110 patients followed
up at an autoimmune disease consultation, mainly female.
Results: The main reason for performing Nailfold capillaroscopy
was the study of Raynaud’s phenomenon,
mainly secondary cases (67.4%), being the most frequent
underlying pathology the systemic sclerosis. Significant
changes were not found in the capillaries architecture in
27.3% (n = 30). In the remaining, we found minor changes
in 28 cases, presence of megacapillaries in 41 patients
(37.3%), avascular areas in 35 (37.8%), microhemorrhages
in 36 patients (32.7%) and signs of neoangiogenesis in five
(4.5%). The majority of systemic sclerosis patients have
secondary Raynaud’s. Only two patients with systemic
sclerosis did not have a well-defined scleroderma pattern
in the nailfold capillaroscopy.
Conclusion: The nailfold capillaroscopy effectiveness on
early diagnosis of systemic sclerosis, on monitoring disease
progression and in the prediction of organ involvement,
making it an essential noninvasive method, as
supported by its inclusion in the systemic sclerosis classification
criteria.

Downloads

Download data is not yet available.

References

Rosário e Souza EJ, Kayser C. Capilaroscopia periungueal: relevância para a prática reumatológica. Rev Bras Reumatol. 2015;55:264-71.

Rossi D, Russo A, Manna E, Binello G, Baldovino S, Sciascia S, et al. The role of nail-videocapillaroscopy in early diagnosis of scleroderma. Autoimmun Rev. 2013;12:821-5.

Cutolo M, Pizzorni C, Sulli A. Nailfold video-capillaroscopy in systemic sclerosis. Rheumatology. 2004;63:457–62.

Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. Classification Criteria for Systemic Sclerosis: An ACR-EULAR Collaborative Initiative. Arthritis Rheum. 2013; 65; 2737–47.

Meli M, Gitzelmann G, Koppensteiner R, Amann-Vesti BR. Predictive value of nailfold capillaroscopy in patients with Raynaud´s phenomenon. Clin Rheumatol. 2006;25:153-8.

Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev. 2011;10:641–6.

Cutolo M, Pizzorni C, Sulli A. Identification of transition from primary Raynaud´s phenomenon to secondary Raynaud´s phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al. Arthritis Rheum. 2007;56:2102–3.

Ghizzoni C, Sebastiani M, Manfredi A, Campomori F, Colaci M, Giuggioli D, et al. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. Microvasc Res. 2015; 99:92– 5.

Jammal M, Kettaneh A, Cabane J, Tiev K, Toledano C. Periungueal capillaroscopy: an easy and reliable method to evaluate all microcirculation diseases. Rev Med Interne. 2015;36:603-12.

Sambataro D, Sambataro G, Zaccara E, Maglione W, Polosa R, Afeltra AM, et al. Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis. Arthritis Res Ther. 2014;16: 462.

Alan S, Balkarlı A, Tuna S, Özkan U, Temel S, Özhan N, et al. The nailfold videocapillaroscopy findings of Behçet’s syndrome. Dermatol Sinica. 2016;34:74-7.

Young HR, Seong JC, Young HL, Jong DJ, Gwan GS. Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int. 2006;26:369–75.

Sosada B, Loza K, Bialo-Wojcicka E. Relapsing polychondritis. Case Rep Dermatol Med. 2014;2014:791951.

Adegunsoye A, Oldham JM, Demchuk C, Montner S, Vij R, Strek ME. Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016;114:53-60.

Overbury R, Murtaugh MA, Fischer A, Frech TM. Primary care assessment of capillaroscopy abnormalities in patients with Raynaud´s phenomenon. Clin Rheumatol. 2015;34:2135-40.

Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: Evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 2013;65:1953-62.

Chora I, Guiducci S, Manetti M, Romano E, Mazzotta C, Bellando-Randone S, et al. Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis. Autoimmun Rev. 2015;14:314-22.

Le Roy EC, Medsger Jr. TA. Raynaud´s phenomenon: a proposal for classification. Clin Exp Rheumatol. 1992; 10: 485-8.

Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud´s phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58:3902-12.

Miniati I, Guiducci S, Conforti ML, Rogai V, Fiori G, Cinelli M, et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis. 2009;68:94-8.

Cutolo M, Zampogna G, Vremis L, Smith V, Pizzorni C, Sulli A. Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis. J Rheumatol. 2013;40:40-5.

Cutolo M, Ruaro B, Pizzorni C, Ravera F, Smith V, Zampogna G, et al. Long-term treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. J Rheumatol. 2014;41:881-6.

Additional Files

Published

2017-12-29

How to Cite

1.
Silva J, Monteiro P, Fernandes R, Malheiro J, Silva C, Ferreira P, Seixas A, Paixão Dias V. Nailfold Capillaroscopy in the Evaluation of Autoimmune Diseases. RPMI [Internet]. 2017 Dec. 29 [cited 2024 Nov. 23];24(4):285-9. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/759

Issue

Section

Original Articles

Most read articles by the same author(s)